You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Public Health England is now aiming to validate the test on around 2,000 samples and accredit it in order to offer it as a routine clinical diagnostic.
Contrary to the notion that Europeans introduced tuberculosis to Africa, sequencing data suggests the bacterium was already there.
The partners are broadening their collaboration to bring point-of-care TB diagnostics to all levels of the health system in low- and middle-income countries.
The agency will fund projects identifying and/or validating non-sputum biomarkers of TB disease in children, particularly those under five.
In PLOS this week: gene expression profiles of gestation in pigs, genomic comparison of Mycobacterium bovis and M. caprae, and more.
In PLOS this week: recombination density-based method for calibrating human mutation rates, pathogen-typing approach using solid-state nanopores, and more.
Adjusted revenues grew 2 percent year over year, highlighted by growth in the company's QuantiFERON-TB test and an expansion of pharma partnerships for companion diagnostics.
In PNAS this week: genome and transcriptome of the Asian tiger mosquito, TB diversity and virulence in Inuit populations, and more.
Genome sequence data revealed a single Mycobacterium tuberculosis introduction to northern Quebec in the early 20th century, without a subsequent rise in virulence.
The database of genotype, phenotype, and clinical data from multi-drug resistant TB cases may support improved diagnostic development and clinical decision making.
Following discrimination allegations, NICHD's Constantine Stratakis withdraws from a new position at the Research Institute of the McGill University Health Center, Science reports.
US President Donald Trump has threatened to cut World Health Organization funding over its pandemic response, which would affect its ability to do its work and which he might not be able to do.
The US Securities and Exchange Commission has halted the sales of a handful of stocks over claims made about the coronavirus.
In Nature this week: comparative analyses of single-cell RNA sequencing protocols uncover differences between approaches, and more.